UIC researchers have redesigned asparaginase, a key leukemia treatment, to reduce severe side effects like liver damage and ...

This valuable study presents a mouse gastruloid model that can be used to generate hematopoietic progenitors as well as leukemic cells. However, in its current form, the manuscript is inadequate ...

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its ...

The CD34+CD38− cells, isolated from acute myeloid leukemia (AML), were shown to be ... Comparison of the LSC expression data to that of normal hematopoietic stem cells (HSC) revealed that ...

Wiedemann-Steiner syndrome (WSS) research reveals MLL protein's role in neurodevelopment and potential therapeutic avenues for treatment.

The normal dense rat bone marrow containing ... history of illness was given the diagnosis of myelogenous leukemia. The white-cell count was 181,000. Severe joint pain and swelling required ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell lymphoma.

Targeted therapies for high-risk leukemia in children have yet ... specifically because they eliminate cancer cells without affecting normal cells. This nuance is crucial for the development ...